 Connection
Ronda Henry-Tillman to Carcinoma, Ductal, Breast
This is a "connection" page, showing publications Ronda Henry-Tillman has written about Carcinoma, Ductal, Breast.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.380 |
|
|
|
-
Makhoul I, Klimberg VS, Korourian S, Henry-Tillman RS, Siegel ER, Westbrook KC, Hutchins LF. Combined neoadjuvant chemotherapy with bevacizumab improves pathologic complete response in patients with hormone receptor negative operable or locally advanced breast cancer. Am J Clin Oncol. 2015 Feb; 38(1):74-9.
Score: 0.117
-
Burdge EC, Yuen J, Hardee M, Gadgil PV, Das C, Henry-Tillman R, Ochoa D, Korourian S, Suzanne Klimberg V. Nipple skin-sparing mastectomy is feasible for advanced disease. Ann Surg Oncol. 2013 Oct; 20(10):3294-302.
Score: 0.106
-
Klimberg VS, Boneti C, Adkins LL, Smith M, Siegel E, Zharov V, Ferguson S, Henry-Tillman R, Badgwell B, Korourian S. Feasibility of percutaneous excision followed by ablation for local control in breast cancer. Ann Surg Oncol. 2011 Oct; 18(11):3079-87.
Score: 0.093
-
Kepple J, Henry-Tillman RS, Klimberg VS, Layeeque R, Siegel E, Westbrook K, Korourian S. The receptor expression pattern in ductal carcinoma in situ predicts recurrence. Am J Surg. 2006 Jul; 192(1):68-71.
Score: 0.065
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|